Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update

被引:63
作者
Kitajima, Kazuhiro [1 ,2 ]
Nakajo, Masatoyo [3 ]
Kaida, Hayato [4 ]
Minamimoto, Ryogo [5 ]
Hirata, Kenji [6 ]
Tsurusaki, Masakatsu [4 ]
Doi, Hiroshi [7 ]
Ueno, Yoshiko [8 ]
Sofue, Keitaro [8 ]
Tamaki, Yukihisa [9 ]
Yamakado, Koichiro [10 ]
机构
[1] Hyogo Coll Med, Div Nucl Med, Dept Radiol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
[2] Hyogo Coll Med, PET Ctr, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
[3] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, Kagoshima, Japan
[4] Kinki Univ, Dept Radiol, Fac Med, Osaka, Japan
[5] Natl Ctr Global Hlth & Med, Div Nucl Med, Dept Radiol, Tokyo, Japan
[6] Hokkaido Univ, Dept Nucl Med, Grad Sch Med, Sapporo, Hokkaido, Japan
[7] Kinki Univ, Dept Radiat Oncol, Fac Med, Osaka, Japan
[8] Kobe Univ, Dept Radiol, Grad Sch Med, Kobe, Hyogo, Japan
[9] Shimane Univ, Dept Radiat Oncol, Sch Med, Izumo, Shimane, Japan
[10] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo, Japan
来源
NAGOYA JOURNAL OF MEDICAL SCIENCE | 2017年 / 79卷 / 04期
关键词
fluorodeoxyglucose (FDG); positron emission tomography/computed tomography (PET/CT); esophageal cancer; gastric cancer; colorectal cancer; POSITRON-EMISSION-TOMOGRAPHY; PATHOLOGICAL COMPLETE RESPONSE; RECURRENT COLORECTAL-CANCER; ADVANCED RECTAL-CANCER; ESOPHAGEAL CANCER; F-18-FDG PET; NEOADJUVANT CHEMORADIATION; GASTRIC-CANCER; PREOPERATIVE CHEMORADIOTHERAPY; PROGNOSTIC-SIGNIFICANCE;
D O I
10.18999/nagjms.79.4.527
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Positron emission tomography/computed tomography (PET/CT) integrated with 2-[F-18] fluoro-2-deoxy-D-glucose (FDG) is a useful tool for acquisition of both glucose metabolism and anatomic imaging data, as only a single device and one diagnostic session is required, thus opening a new field in clinical oncologic imaging. FDG-PET/CT has been successfully used for initial staging, restaging, assessment of early treatment response, evaluation of metastatic disease response, and prognostication of intestinal cancer as well as various malignant tumors. We reviewed the current status and role of FDG-PET/CT for management of patients with esophageal cancer, gastric cancer, and colorectal cancer, with focus on both its usefulness and limitations.
引用
收藏
页码:527 / 543
页数:17
相关论文
共 54 条
[1]   Staging and preoperative evaluation of upper gastrointestinal malignancies [J].
Abdalla, EK ;
Pisters, PWT .
SEMINARS IN ONCOLOGY, 2004, 31 (04) :513-529
[2]   Follow-Up After Gastrectomy for Cancer: An Appraisal of the Italian Research Group for Gastric Cancer [J].
Baiocchi, Gian Luca ;
Marrelli, Daniele ;
Verlato, Giuseppe ;
Morgagni, Paolo ;
Giacopuzzi, Simone ;
Coniglio, Arianna ;
Marchet, Alberto ;
Rosa, Fausto ;
Capponi, Michela Giulii ;
Di Leo, Alberto ;
Saragoni, Luca ;
Ansaloni, Luca ;
Pacelli, Fabio ;
Nitti, Donato ;
D'Ugo, Domenico ;
Roviello, Franco ;
Tiberio, Guido A. M. ;
Giulini, Stefano M. ;
De Manzoni, Giovanni .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (06) :2005-2011
[3]   18F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer: A Prospective Study with Mature Survival Data [J].
Barber, Thomas W. ;
Duong, Cuong P. ;
Leong, Trevor ;
Bressel, Mathias ;
Drummond, Elizabeth G. ;
Hicks, Rodney J. .
JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (06) :864-871
[4]   The value of FDG positron emission tomography/computerised tomograph (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation [J].
Brush, J. ;
Boyd, K. ;
Chappell, F. ;
Crawford, F. ;
Dozier, M. ;
Fenwick, E. ;
Glanville, J. ;
McIntosh, H. ;
Renehan, A. ;
Weller, D. ;
Dunlop, M. .
HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (35) :1-+
[5]   Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort [J].
Cheedella, N. K. S. ;
Suzuki, A. ;
Xiao, L. ;
Hofstetter, W. L. ;
Maru, D. M. ;
Taketa, T. ;
Sudo, K. ;
Blum, M. A. ;
Lin, S. H. ;
Welch, J. ;
Lee, J. H. ;
Bhutani, M. S. ;
Rice, D. C. ;
Vaporciyan, A. A. ;
Swisher, S. G. ;
Ajani, J. A. .
ANNALS OF ONCOLOGY, 2013, 24 (05) :1262-1266
[6]   Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography [J].
Chen, J ;
Cheong, JH ;
Yun, MJ ;
Kim, J ;
Lim, JS ;
Hyung, WJ ;
Noh, SH .
CANCER, 2005, 103 (11) :2383-2390
[7]   Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy [J].
Chen, Shang-Wen ;
Hsieh, Te-Chun ;
Ding, Hueisch-Jy ;
Yen, Kuo-Yang ;
Lin, Chen-Yuan ;
Liang, Ji-An ;
Kao, Chia-Hung .
NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (03) :291-297
[8]   Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis [J].
Chen, Yu-mei ;
Pan, Xu-feng ;
Tong, Lin-jun ;
Shi, Yi-ping ;
Chen, Tao .
NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (11) :1005-1010
[9]   Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3NO prostatic carcinoma: the dummy run [J].
Davis, JB ;
Reiner, B ;
Dusserre, A ;
Giraud, JY ;
Bolla, M .
RADIOTHERAPY AND ONCOLOGY, 2002, 64 (01) :65-73
[10]   Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection [J].
Even-Sapir, E ;
Parag, Y ;
Lerman, H ;
Gutman, M ;
Levine, C ;
Rabau, M ;
Figer, A ;
Metser, U .
RADIOLOGY, 2004, 232 (03) :815-822